<?xml version='1.0' encoding='utf-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd">
<article article-type="research-article" dtd-version="1.2" xml:lang="ru" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="issn">2658-6533</journal-id><journal-title-group><journal-title>Научные результаты биомедицинских исследований</journal-title></journal-title-group><issn pub-type="epub">2658-6533</issn></journal-meta><article-meta><article-id pub-id-type="doi">10.18413/2658-6533-2024-10-2-0-4</article-id><article-id pub-id-type="publisher-id">3421</article-id><article-categories><subj-group subj-group-type="heading"><subject>Генетика</subject></subj-group></article-categories><title-group><article-title>&lt;strong&gt;Генетический вариант rs11568818 матриксной металлопротеиназы 7 ассоциирован с весом новорожденного у беременных с задержкой роста плода&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</article-title><trans-title-group xml:lang="en"><trans-title>&lt;strong&gt;Genetic variant &lt;/strong&gt;&lt;strong&gt;rs11568818 of matrix metalloproteinase &lt;em&gt;MMP7&lt;/em&gt; associated with newborn weight in pregnant women with fetal growth restriction&lt;/strong&gt;&lt;br /&gt;
&amp;nbsp;</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Решетникова</surname><given-names>Юлия Николаевна</given-names></name><name xml:lang="en"><surname>Reshetnikova</surname><given-names>Yuliya N.</given-names></name></name-alternatives><email>resh_yul@mail.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Пономаренко</surname><given-names>Ирина Васильевна</given-names></name><name xml:lang="en"><surname>Ponomarenko</surname><given-names>Irina V.</given-names></name></name-alternatives><email>ponomarenko_i@bsu.edu.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Чурносов</surname><given-names>Владимир Иванович</given-names></name><name xml:lang="en"><surname>Churnosov</surname><given-names>Vladimir I.</given-names></name></name-alternatives><email>vchurnosov@yandex.kz</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Пономаренко</surname><given-names>Марина Сергеевна</given-names></name><name xml:lang="en"><surname>Ponomarenko</surname><given-names>Marina S.</given-names></name></name-alternatives><email>ponomarenkomc@yandex.ru</email></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="ru"><surname>Решетников</surname><given-names>Евгений Александрович</given-names></name><name xml:lang="en"><surname>Reshetnikov</surname><given-names>Evgeny A.</given-names></name></name-alternatives><email>reshetnikov@bsu.edu.ru</email></contrib></contrib-group><pub-date pub-type="epub"><year>2024</year></pub-date><volume>10</volume><issue>2</issue><fpage>0</fpage><lpage>0</lpage><self-uri content-type="pdf" xlink:href="/media/medicine/2024/2/Биомедицинские_исследования-53-64.pdf" /><abstract xml:lang="ru"><p>Актуальность: Задержка роста плода (ЗРП) является распространенным осложнением беременности, частота которого достигает 10% во всем мире. ЗРП является основной причиной мертворождений и неонатальной заболеваемости и смертности, а долгосрочные последствия ЗРП связаны с более частой встречаемостью сердечно-сосудистых и метаболических заболеваний во взрослом возрасте. Цель исследования: Изучить ассоциации полиморфизма генов матриксных металлопротеиназ с весом новорожденных у беременных с задержкой роста плода и оценить их функциональные эффекты. Материалы и методы: На выборке беременных с задержкой роста плода (n=98) проведено молекулярно-генетическое исследование пяти полиморфных локусов генов матриксных металлопротеиназ (rs1799750 MMP-1, rs243865 MMP-2, rs3025058 MMP-3, rs11568818 MMP-7, rs17577 MMP-9). Результаты: Установлены ассоциации полиморфизма rs11568818 гена MMP-7 с весом новорожденного у женщин с задержкой роста плода в рамках рецессивной модели (&amp;beta; = 0,32&amp;plusmn;0,13, p=0,016 pperm=0,022). Данный полиморфный локус обладает важными функциональными эффектами. Он локализуется в регионе гиперчувствительности к ДНКазе и сайте модифицированных гистонов, маркирующих энхансеры и промоторы в мезенхимальных и гемопоэтических стволовых клетках, клетках остеобластов, адипоцитов, клеточной линии фибробластов легких, различных отделов головного мозга, легких и др., определяет чувствительность ДНК к четырем факторам транскрипции (Foxa, GR, PLZF, Pou5f1), связан с уровнем экспрессии мРНК гена MMP-7 в легких, печени, скелетной мускулатуре. Заключение: Полиморфизм rs11568818 гена MMP-7 ассоциирован с весом новорожденного у женщин с задержкой роста плода</p></abstract><trans-abstract xml:lang="en"><p>Background: Fetal growth restriction is a common complication of pregnancy that has been associated with a variety of adverse perinatal outcomes. The condition carries significant risks of neonatal mortality, major and minor morbidity, and long term health sequelae. The aim of the study: The aim of the study was to study the associations of matrix metalloproteinases gene polymorphism with newborn weight in pregnant women with fetal growth restriction and to evaluate their functional effects. Materials and methods: 98 cases of women with fetal growth restriction were selected as the experimental group. All pregnant women were performed genotyping of 5 SNPs of genes of matrix metalloproteinase (rs1799750 MMP-1, rs243865 MMP-2, rs3025058 MMP-3, rs11568818 MMP-7, rs17577 MMP-9). Results: We found associations of the rs11568818 polymorphism of the MMP-7 gene with newborn weight in women with fetal growth restriction within a recessive model (&amp;beta; = 0.32&amp;plusmn;0.13, p=0.016 pperm=0.022). This polymorphic locus possesses important functional effects. It is localized in an evolutionarily conserved region, a binding site for regulatory proteins (TBP, CFOS, CJUN), a region of DNase hypersensitivity, and a site of modified histones marking enhancers and promoters in mesenchymal and hematopoietic stem cells, osteoblast cells, adipocytes, and fibroblast cell line lungs, various parts of the brain, lungs, etc., determines the sensitivity of DNA to four transcription factors (Foxa, GR, PLZF, Pou5f1), is associated with the level of mRNA expression of the MMP-7 gene in the lungs, liver, and skeletal muscles. Conclusion: The rs11568818 polymorphism of the MMP-7 gene is associated with a newborn weight</p></trans-abstract><kwd-group xml:lang="ru"><kwd>задержка роста плода</kwd><kwd>однонуклеотидный полиморфизм</kwd><kwd>матриксные металлопротеиназы</kwd><kwd>MMP-7</kwd><kwd>ассоциации</kwd><kwd>вес новорожденного</kwd></kwd-group><kwd-group xml:lang="en"><kwd>fetal growth restriction</kwd><kwd>single-nucleotide polymorphism</kwd><kwd>matrix metalloproteinase</kwd><kwd>MMP-7</kwd><kwd>associations</kwd><kwd>newborn weight</kwd></kwd-group></article-meta></front><back><ref-list><title>Список литературы</title><ref id="B1"><mixed-citation>Martins JG, Biggio JR, Abuhamad A, et al. Society for Maternal-Fetal Medicine Consult Series #52: Diagnosis and management of fetal growth restriction: (Replaces Clinical Guideline Number 3, April 2012). American Journal of Obstetrics and Gynecology. 2020;223(4):B2-B17. DOI: https://doi.org/10.1016/j.ajog.2020.05.010</mixed-citation></ref><ref id="B2"><mixed-citation>Головченко ОВ. Молекулярно-генетические детерминанты преэклампсии. Научные результаты биомедицинских исследований. 2019;5(4):139-149. DOI: https://doi.org/10.18413/2658-6533-2019-5-4-0-11</mixed-citation></ref><ref id="B3"><mixed-citation>Решетников ЕА. Поиск ассоциаций генов-кандидатов, дифференциально экспрессирующихся в плаценте, с риском развития плацентарной недостаточности с синдромом задержки роста плода. Научные результаты биомедицинских исследований. 2020;6(3):338-349. DOI: https://doi.org/10.18413/2658-6533-2020-6-3-0-5</mixed-citation></ref><ref id="B4"><mixed-citation>Баев ТО, Панова ИА, Кузьменко ГН, и др. Состояние микроциркуляции у беременных женщин с гипертензивными расстройствами в III триместре беременности. Научные результаты биомедицинских исследований. 2023;9(1):113-128. DOI: https://doi.org/10.18413/2658-6533-2023-9-1-0-8</mixed-citation></ref><ref id="B5"><mixed-citation>Pels A, Beune IM, van Wassenaer-Leemhuis AG, et al. Early-onset fetal growth restriction: A systematic review on mortality and morbidity. Acta Obstetricia et Gynecologica Scandinavica. 2020;99(2):153-166. DOI: https://doi.org/10.1111/aogs.13702</mixed-citation></ref><ref id="B6"><mixed-citation>D&amp;#39;Agostin M, Di Sipio Morgia C, Vento G, et al. Long-term implications of fetal growth restriction. World Journal of Clinical Cases. 2023;11(3):2855-2863. DOI: https://doi.org/10.12998/wjcc.v11.i13.2855</mixed-citation></ref><ref id="B7"><mixed-citation>Anil KC, Basel PL, Singh S. Low birth weight and its associated risk factors: Health facility-based case-control study. PLoS ONE. 2020;15(6):e0234907. DOI: https://doi.org/10.1371/journal.pone.0234907</mixed-citation></ref><ref id="B8"><mixed-citation>Burton GJ, Jauniaux E. Pathophysiology of placental-derived fetal growth restriction. American Journal of Obstetrics and Gynecology. 2018;218(2):S745-S761. DOI: https://doi.org/10.1016/j.ajog.2017.11.577</mixed-citation></ref><ref id="B9"><mixed-citation>Cabral-Pacheco GA, Garza-Veloz I, Castruita-De la Rosa C, et al. The Roles of Matrix Metalloproteinases and Their Inhibitors in Human Diseases. International Journal of Molecular Sciences. 2020;21(24):9739. DOI: https://doi.org/10.3390/ijms21249739</mixed-citation></ref><ref id="B10"><mixed-citation>Chen J, Khalil RA. Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia. Progress in Molecular Biology and Translational Science. 2017;148:87-165. DOI: https://doi.org/10.1016/bs.pmbts.2017.04.001</mixed-citation></ref><ref id="B11"><mixed-citation>Laronha H, Caldeira J. Structure and Function of Human Matrix Metalloproteinases. Cells. 2020;9(5):1076. DOI: https://doi.org/10.3390/cells9051076</mixed-citation></ref><ref id="B12"><mixed-citation>Hiden U, Ghaffari-Tabrizi N, Gauster M, et al. Membrane-type matrix metalloproteinase 1 regulates trophoblast functions and is reduced in fetal growth restriction. American Journal of Pathology. 2013;182(5):1563-71. DOI: https://doi.org/10.1016/j.ajpath.2013.01.011</mixed-citation></ref><ref id="B13"><mixed-citation>Zhu J, Zhong M, Pang ZJ, et al. Dysregulated expression of matrix metalloproteinases and their inhibitors may participate in the pathogenesis of pre-eclampsia and fetal growth restriction. Early Human Development. 2014;90(10):657-664. DOI: https://doi.org/10.1016/j.earlhumdev.2014.08.007</mixed-citation></ref><ref id="B14"><mixed-citation>Su MT, Tsai PY, Tsai HL, et al. miR-346 and miR-582-3p-regulated EG-VEGF expression and trophoblast invasion via matrix metalloproteinases 2 and 9. BioFactors. 2017;43(2):210-219. DOI: https://doi.org/10.1002/biof.1325</mixed-citation></ref><ref id="B15"><mixed-citation>Garcha D, Walker SP, MacDonald TM, et al. Circulating syndecan-1 is reduced in pregnancies with poor fetal growth and its secretion regulated by matrix metalloproteinases and the mitochondria. Scientific Reports. 2021;11(1):16595. DOI: https://doi.org/10.1038/s41598-021-96077-1</mixed-citation></ref><ref id="B16"><mixed-citation>Şahin B, Soyer-&amp;Ccedil;alışkan C, &amp;Ccedil;elik S, et al. Midregional pro-adrenomedullin and matrix metalloproteinase-2 levels in intrauterine growth restriction and small gestational age pregnancies: biochemical diagnostic difference. Journal of Maternal-Fetal and Neonatal Medicine. 2021;34(12):1999-2005. DOI: https://doi.org/10.1080/14767058.2020.1846707</mixed-citation></ref><ref id="B17"><mixed-citation>Pei J, Li Y, Min Z, et al. MiR-590-3p and its targets VEGF, PIGF, and MMP9 in early, middle, and late pregnancy: their longitudinal changes and correlations with risk of fetal growth restriction. Irish Journal of Medical Science. 2022;191(3):1251-1257. DOI: https://doi.org/10.1007/s11845-021-02664-6</mixed-citation></ref><ref id="B18"><mixed-citation>Laskowska M, Dymara-Konopka W, Szmit E, et al. Matrix metalloproteinase-3 in preeclamptic and normotensive pregnancies complicated by foetal growth restriction. Heliyon. 2023;9(7):e18105. DOI: https://doi.org/10.1016/j.heliyon.2023.e18105</mixed-citation></ref><ref id="B19"><mixed-citation>Gremlich S, Nguyen D, Reymondin D, et al. Fetal MMP2/MMP9 polymorphisms and intrauterine growth restriction risk. Journal of Reproductive Immunology. 2007;74(1-2):143-151. DOI: https://doi.org/10.1016/j.jri.2007.02.001</mixed-citation></ref><ref id="B20"><mixed-citation>Edwards DRV, Romero R, Kusanovic JP, et al. Polymorphisms in maternal and fetal genes encoding for proteins involved in extracellular matrix metabolism alter the risk for small-for-gestational-age. Journal of Maternal-Fetal and Neonatal Medicine. 2011;24(2):362-380. DOI: https://doi.org/10.3109/14767058.2010.497572</mixed-citation></ref><ref id="B21"><mixed-citation>Sakowicz A, Lisowska M, Biesiada L, et al. Association of Maternal and Fetal Single-Nucleotide Polymorphisms in Metalloproteinase (MMP1, MMP2, MMP3, and MMP9) Genes with Preeclampsia. Disease Markers. 2018;2018:1371425. DOI: https://doi.org/10.1155/2018/1371425</mixed-citation></ref><ref id="B22"><mixed-citation>Gannoun MBA, Raguema N, Zitouni H, et al. MMP-2 and MMP-9 Polymorphisms and Preeclampsia Risk in Tunisian Arabs: A Case-Control Study. Journal of Clinical Medicine. 2021;10(12):2647. DOI: https://doi.org/10.3390/jcm10122647</mixed-citation></ref><ref id="B23"><mixed-citation>Jia JP, Wu JH, Hu JR. Correlations of MMP-9 and PPAR&amp;gamma; gene polymorphisms with occurrence of preeclampsia. European Review for Medical and Pharmacological Sciences. 2022;26(3):771-778. DOI: https://doi.org/10.26355/eurrev_202202_27985</mixed-citation></ref><ref id="B24"><mixed-citation>Пономаренко ИВ, Решетников ЕА, Полоников АВ, и др. Полиморфный локус rs314276 гена LIN28B ассоциирован с возрастом менархе у женщин Центрального Черноземья России. Акушерство и гинекология. 2019;2:98-104. DOI: https://dx.doi.org/10.18565/aig.2019.2.98-104</mixed-citation></ref><ref id="B25"><mixed-citation>Wang X, Khalil RA. Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease. Advances in Pharmacology. 2018;81:241-330. DOI: https://doi.org/10.1016/bs.apha.2017.08.002</mixed-citation></ref><ref id="B26"><mixed-citation>Espino Y Sosa S, Flores-Pliego A, Espejel-Nu&amp;ntilde;ez A, et al. New Insights into the Role of Matrix Metalloproteinases in Preeclampsia. International Journal of Molecular Sciences. 2017;18(7):1448. DOI: https://doi.org/10.3390/ijms18071448</mixed-citation></ref><ref id="B27"><mixed-citation>Reister F, Kingdom JCP, Ruck P, et al. Altered protease expression by periarterial trophoblast cells in severe early-onset preeclampsia with IUGR. Journal of Perinatal Medicine. 2006;34(4):272-279. DOI: https://doi.org/10.1515/JPM.2006.052</mixed-citation></ref><ref id="B28"><mixed-citation>Conti DV, Darst BF, Moss LC, et al. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics. 2021;53(3):413. DOI: https://doi.org/10.1038/s41588-021-00786-2</mixed-citation></ref><ref id="B29"><mixed-citation>Emami NC, Cavazos TB, Rashkin SR, et al. A Large-Scale Association Study Detects Novel Rare Variants, Risk Genes, Functional Elements, and Polygenic Architecture of Prostate Cancer Susceptibility. Cancer Research. 2021;81(7):1695-1703. DOI: https://doi.org/10.1158/0008-5472.CAN-20-2635</mixed-citation></ref><ref id="B30"><mixed-citation>Das AP, Chopra M, Agarwal SM. Prioritization and Meta-analysis of regulatory SNPs identified IL6, TGFB1, TLR9 and MMP7 as significantly associated with cervical cancer. Cytokine. 2022;157:155954. DOI: https://doi.org/10.1016/j.cyto.2022.155954</mixed-citation></ref></ref-list></back></article>